Koronis Pharmaceuticals, Inc.
Records under this name other than patents Koronis Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to Koronis Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,648,967 | Mutagenic nucleoside analogs for the treatment of viral disease Lapsed on the fee record Ended Jan 19, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jan 19, 2022 | From the USPTO record |
| US 7,642,247 | 1,3,5-triazines for treatment of viral diseases Lapsed on the fee record Ended Jan 5, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jan 5, 2022 | From the USPTO record |
| US 7,589,092 | Prodrugs of heteroaryl compounds Lapsed on the fee record Ended Sep 15, 2021 · From the USPTO record | Lapsed on the fee record | Ended Sep 15, 2021 | From the USPTO record |
| US 8,324,379 | Prodrugs of heteroaryl compounds Lapsed on the fee record Ended Dec 4, 2020 · From the USPTO record | Lapsed on the fee record | Ended Dec 4, 2020 | From the USPTO record |
| US 7,982,034 | Prodrugs of heteroaryl compounds Lapsed on the fee record Ended Jul 19, 2019 · From the USPTO record | Lapsed on the fee record | Ended Jul 19, 2019 | From the USPTO record |
| US 7,244,717 | Mutagenic nucleoside analogs for the treatment of viral disease Lapsed on the fee record Ended Jul 17, 2019 · From the USPTO record | Lapsed on the fee record | Ended Jul 17, 2019 | From the USPTO record |
| US 7,244,732 | Prodrugs of heteroaryl compounds Lapsed on the fee record Ended Jul 17, 2019 · From the USPTO record | Lapsed on the fee record | Ended Jul 17, 2019 | From the USPTO record |
| US 7,772,197 | 1,3,5-triazines for treatment of viral diseases Lapsed on the fee record Ended Aug 10, 2014 · From the USPTO record | Lapsed on the fee record | Ended Aug 10, 2014 | From the USPTO record |